Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study

Background: The prevalence of chronic comorbidities is increasing worldwide, and this has been paralleled by a growing interest in how these comorbidities affect patients with acute pancreatitis. The aim was to investigate the associations between pre-existing diabetes mellitus, obesity, metabolic s...

Full description

Bibliographic Details
Main Authors: Rachel Goodger, Kanageswari Singaram, Maxim S. Petrov
Format: Article
Language:English
Published: Karger Publishers 2021-11-01
Series:Biomedicine Hub
Subjects:
Online Access:https://www.karger.com/Article/FullText/519826
_version_ 1818341677910196224
author Rachel Goodger
Kanageswari Singaram
Maxim S. Petrov
author_facet Rachel Goodger
Kanageswari Singaram
Maxim S. Petrov
author_sort Rachel Goodger
collection DOAJ
description Background: The prevalence of chronic comorbidities is increasing worldwide, and this has been paralleled by a growing interest in how these comorbidities affect patients with acute pancreatitis. The aim was to investigate the associations between pre-existing diabetes mellitus, obesity, metabolic syndrome, and gastrointestinal symptoms during the early course of acute pancreatitis. Methods: This was a prospective cohort study of patients with a primary diagnosis of acute pancreatitis. Study groups were formed based on the presence of metabolic comorbidities (pre-existing diabetes mellitus, obesity, and metabolic syndrome). Patient-reported outcomes (nausea, bloating, and abdominal pain) were collected prospectively every 24 h (including weekends and public holidays) over the first 72 h of hospitalization. Results: A total of 183 consecutive patients were enrolled. Of them, 111 (61%) had at least one major metabolic comorbidity. Patients with pre-existing diabetes mellitus and those with metabolic syndrome had worse nausea at 49–72 h of hospitalization (p = 0.017 and p = 0.012, respectively), but not at other time points. Bloating and abdominal pain did not differ between the study groupings throughout the study period. The studied patient-reported outcomes did not differ significantly between acute pancreatitis patients with and without obesity at any point in time. Conclusion: More than 3 out of 5 patients hospitalized for acute pancreatitis have at least one major chronic metabolic comorbidity. The presence of metabolic comorbidities does not considerably and consistently affect early gastrointestinal symptoms in patients with acute pancreatitis.
first_indexed 2024-12-13T16:02:36Z
format Article
id doaj.art-985eb112d02d4536a5d69260b1c1e4fe
institution Directory Open Access Journal
issn 2296-6870
language English
last_indexed 2024-12-13T16:02:36Z
publishDate 2021-11-01
publisher Karger Publishers
record_format Article
series Biomedicine Hub
spelling doaj.art-985eb112d02d4536a5d69260b1c1e4fe2022-12-21T23:39:07ZengKarger PublishersBiomedicine Hub2296-68702021-11-016311111710.1159/000519826519826Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort StudyRachel GoodgerKanageswari SingaramMaxim S. Petrovhttps://orcid.org/0000-0002-5923-9062Background: The prevalence of chronic comorbidities is increasing worldwide, and this has been paralleled by a growing interest in how these comorbidities affect patients with acute pancreatitis. The aim was to investigate the associations between pre-existing diabetes mellitus, obesity, metabolic syndrome, and gastrointestinal symptoms during the early course of acute pancreatitis. Methods: This was a prospective cohort study of patients with a primary diagnosis of acute pancreatitis. Study groups were formed based on the presence of metabolic comorbidities (pre-existing diabetes mellitus, obesity, and metabolic syndrome). Patient-reported outcomes (nausea, bloating, and abdominal pain) were collected prospectively every 24 h (including weekends and public holidays) over the first 72 h of hospitalization. Results: A total of 183 consecutive patients were enrolled. Of them, 111 (61%) had at least one major metabolic comorbidity. Patients with pre-existing diabetes mellitus and those with metabolic syndrome had worse nausea at 49–72 h of hospitalization (p = 0.017 and p = 0.012, respectively), but not at other time points. Bloating and abdominal pain did not differ between the study groupings throughout the study period. The studied patient-reported outcomes did not differ significantly between acute pancreatitis patients with and without obesity at any point in time. Conclusion: More than 3 out of 5 patients hospitalized for acute pancreatitis have at least one major chronic metabolic comorbidity. The presence of metabolic comorbidities does not considerably and consistently affect early gastrointestinal symptoms in patients with acute pancreatitis.https://www.karger.com/Article/FullText/519826acute pancreatitisdiabetes mellitusobesitymetabolic syndromegastrointestinal symptomspatient-reported outcomes
spellingShingle Rachel Goodger
Kanageswari Singaram
Maxim S. Petrov
Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
Biomedicine Hub
acute pancreatitis
diabetes mellitus
obesity
metabolic syndrome
gastrointestinal symptoms
patient-reported outcomes
title Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
title_full Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
title_fullStr Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
title_full_unstemmed Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
title_short Prevalence of Chronic Metabolic Comorbidities in Acute Pancreatitis and Its Impact on Early Gastrointestinal Symptoms during Hospitalization: A Prospective Cohort Study
title_sort prevalence of chronic metabolic comorbidities in acute pancreatitis and its impact on early gastrointestinal symptoms during hospitalization a prospective cohort study
topic acute pancreatitis
diabetes mellitus
obesity
metabolic syndrome
gastrointestinal symptoms
patient-reported outcomes
url https://www.karger.com/Article/FullText/519826
work_keys_str_mv AT rachelgoodger prevalenceofchronicmetaboliccomorbiditiesinacutepancreatitisanditsimpactonearlygastrointestinalsymptomsduringhospitalizationaprospectivecohortstudy
AT kanageswarisingaram prevalenceofchronicmetaboliccomorbiditiesinacutepancreatitisanditsimpactonearlygastrointestinalsymptomsduringhospitalizationaprospectivecohortstudy
AT maximspetrov prevalenceofchronicmetaboliccomorbiditiesinacutepancreatitisanditsimpactonearlygastrointestinalsymptomsduringhospitalizationaprospectivecohortstudy